Which has the lower trailing P/E, AUPH or BLFS?

AUPH has the lower trailing P/E: AUPH trades at 6.88 and BLFS at 37.72. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AUPH or BLFS?

Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus BLFS at 6.78%.

Is AUPH or BLFS more profitable?

AUPH runs the higher net margin — AUPH at 100.84% versus BLFS at 49.06%.

How have AUPH and BLFS total returns compared?

Over the past 10 years, AUPH delivered 14.53% and BLFS delivered 36.27% annualized total return. Past performance doesn't predict future results.

Aurinia Pharmaceuticals Inc. (AUPH) vs BioLife Solutions, Inc. (BLFS)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and BioLife Solutions, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AUPH

Aurinia Pharmaceuticals Inc.

$2.03B

$15.75HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

BLFS

BioLife Solutions, Inc.

$1.89B

$38.61HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — AUPH vs BLFS

growth of $100 · dividends reinvested · last 10y

AUPH +288.1% (+14.5%/yr)BLFS +2119.0% (+36.3%/yr)BLFS compounded faster over this window

Log scale — wide-divergence pair

AUPH BLFS

AUPH vs BLFS: by the numbers

•AUPH is the larger company ($2.03B vs $1.89B market cap).
•AUPH trades at the lower trailing earnings multiple (6.88 vs 37.72 P/E), one valuation lens rather than an overall verdict.
•AUPH converts more revenue to profit (100.84% vs 49.06% net margin).
•AUPH grew revenue faster over the past five years (40.17% vs 6.78% CAGR).

Metrics side by side

Valuation

Metric	AUPH	BLFS
P/E ratio	6.88	37.72
Forward P/E	16.68	64.35
P/S ratio	6.50	18.35
P/B ratio	3.29	4.49
EV / EBITDA	11.20	170.26
FCF yield	8.57%	N/A

Profitability

Metric	AUPH	BLFS
Gross margin	90.36%	64.48%
Operating margin	37.06%	-1.12%
Net margin	100.84%	49.06%
ROE	51.09%	12.01%
ROIC	21.77%	1.72%

Growth (annualized)

Metric	AUPH	BLFS
Revenue CAGR (5Y)	40.17%	6.78%
Total return CAGR (5Y)	-5.88%	-0.77%

Frequently asked

Which has the lower trailing P/E, AUPH or BLFS?: AUPH has the lower trailing P/E: AUPH trades at 6.88 and BLFS at 37.72. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AUPH or BLFS?: Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus BLFS at 6.78%.
Is AUPH or BLFS more profitable?: AUPH runs the higher net margin — AUPH at 100.84% versus BLFS at 49.06%.
How have AUPH and BLFS total returns compared?: Over the past 10 years, AUPH delivered 14.53% and BLFS delivered 36.27% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AUPH analysis Full BLFS analysis Interactive comparison tool

Dig into the metrics

Aurinia Pharmaceuticals P/E ratio BioLife Solutions P/E ratio Aurinia Pharmaceuticals ROE BioLife Solutions ROE Aurinia Pharmaceuticals operating margin BioLife Solutions operating margin Aurinia Pharmaceuticals revenue growth BioLife Solutions revenue growth Aurinia Pharmaceuticals free cash flow BioLife Solutions free cash flow

Aurinia Pharmaceuticals & BioLife Solutions appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.